149 related articles for article (PubMed ID: 32489258)
21. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
Weber F; Shen L; Aldred MA; Morrison CD; Frilling A; Saji M; Schuppert F; Broelsch CE; Ringel MD; Eng C
J Clin Endocrinol Metab; 2005 May; 90(5):2512-21. PubMed ID: 15713710
[TBL] [Abstract][Full Text] [Related]
22. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852
[TBL] [Abstract][Full Text] [Related]
23. Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features.
Koshikawa T; Fujita N; Ueda N; Ota Y; Sasaki E; Murakami Y; Hosoda W; Yatabe Y; Hanai N; Higuchi M; Hirokawa M; Miyauchi A
Endocr J; 2019 May; 66(5):475-483. PubMed ID: 30867345
[TBL] [Abstract][Full Text] [Related]
24. An antibody-like peptide that recognizes malignancy among thyroid nodules.
Reis CF; Carneiro AP; Vieira CU; Fujimura PT; Morari EC; Silva SJ; Goulart LR; Ward LS
Cancer Lett; 2013 Jul; 335(2):306-13. PubMed ID: 23462224
[TBL] [Abstract][Full Text] [Related]
25. Expression microarray analysis of papillary thyroid carcinoma and benign thyroid tissue: emphasis on the follicular variant and potential markers of malignancy.
Finn SP; Smyth P; Cahill S; Streck C; O'Regan EM; Flavin R; Sherlock J; Howells D; Henfrey R; Cullen M; Toner M; Timon C; O'Leary JJ; Sheils OM
Virchows Arch; 2007 Mar; 450(3):249-60. PubMed ID: 17252232
[TBL] [Abstract][Full Text] [Related]
26. Comparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.
Schulten HJ; Al-Mansouri Z; Baghallab I; Bagatian N; Subhi O; Karim S; Al-Aradati H; Al-Mutawa A; Johary A; Meccawy AA; Al-Ghamdi K; Al-Hamour O; Al-Qahtani MH; Al-Maghrabi J
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S7. PubMed ID: 25923053
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.
Baloch ZW; Abraham S; Roberts S; LiVolsi VA
Hum Pathol; 1999 Oct; 30(10):1166-71. PubMed ID: 10534163
[TBL] [Abstract][Full Text] [Related]
28. Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas.
Dwivedi SS; Khandeparkar SG; Joshi AR; Kulkarni MM; Bhayekar P; Jadhav A; Nayar M; Kambale NS
J Clin Diagn Res; 2016 Dec; 10(12):EC14-EC19. PubMed ID: 28208864
[TBL] [Abstract][Full Text] [Related]
29. Preoperative Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Prospective Analysis.
Strickland KC; Vivero M; Jo VY; Lowe AC; Hollowell M; Qian X; Wieczorek TJ; French CA; Teot LA; Sadow PM; Alexander EK; Cibas ES; Barletta JA; Krane JF
Thyroid; 2016 Oct; 26(10):1466-1471. PubMed ID: 27457786
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Yoo SK; Lee S; Kim SJ; Jee HG; Kim BA; Cho H; Song YS; Cho SW; Won JK; Shin JY; Park do J; Kim JI; Lee KE; Park YJ; Seo JS
PLoS Genet; 2016 Aug; 12(8):e1006239. PubMed ID: 27494611
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
Pyo JS; Kim DH; Yang J
Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
[TBL] [Abstract][Full Text] [Related]
32. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
[TBL] [Abstract][Full Text] [Related]
33. Retinoic acid receptor and retinoid X receptor subtype expression for the differential diagnosis of thyroid neoplasms.
Hoftijzer HC; Liu YY; Morreau H; van Wezel T; Pereira AM; Corssmit EP; Romijn JA; Smit JW
Eur J Endocrinol; 2009 Apr; 160(4):631-8. PubMed ID: 19155317
[TBL] [Abstract][Full Text] [Related]
34. Molecular Testing of Nodules with a Suspicious or Malignant Cytologic Diagnosis in the Setting of Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP).
Strickland KC; Eszlinger M; Paschke R; Angell TE; Alexander EK; Marqusee E; Nehs MA; Jo VY; Lowe A; Vivero M; Hollowell M; Qian X; Wieczorek T; French CA; Teot LA; Cibas ES; Lindeman NI; Krane JF; Barletta JA
Endocr Pathol; 2018 Mar; 29(1):68-74. PubMed ID: 29396809
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier.
Wong KS; Angell TE; Strickland KC; Alexander EK; Cibas ES; Krane JF; Barletta JA
Thyroid; 2016 Jul; 26(7):911-5. PubMed ID: 27219469
[TBL] [Abstract][Full Text] [Related]
36. Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma.
Yano Y; Uematsu N; Yashiro T; Hara H; Ueno E; Miwa M; Tsujimoto G; Aiyoshi Y; Uchida K
Clin Cancer Res; 2004 Mar; 10(6):2035-43. PubMed ID: 15041723
[TBL] [Abstract][Full Text] [Related]
37. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
[TBL] [Abstract][Full Text] [Related]
38. Application of Strict Criteria for Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Encapsulated Follicular Variant Papillary Thyroid Carcinoma: a Retrospective Study of 50 Tumors Previously Diagnosed as Follicular Variant PTC.
Point du Jour K; du Jour KP; Schmitt AC; Chen AY; Griffith CC
Endocr Pathol; 2018 Mar; 29(1):35-42. PubMed ID: 29368294
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of CK19 and CD56 in the differentiation of thyroid papillary carcinoma from its mimics.
Abouhashem NS; Talaat SM
Pathol Res Pract; 2017 May; 213(5):509-517. PubMed ID: 28214214
[TBL] [Abstract][Full Text] [Related]
40. A pathologic re-review of follicular thyroid neoplasms: the impact of changing the threshold for the diagnosis of the follicular variant of papillary thyroid carcinoma.
Widder S; Guggisberg K; Khalil M; Pasieka JL
Surgery; 2008 Jul; 144(1):80-5. PubMed ID: 18571588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]